BLUE BELL, PA — Slipstream IT has secured a strategic investment from GreyLion Partners LP. The funding round also included continued support from Denali Growth Partners (DGP), an existing investor. Financial terms were not disclosed.
The investment aims to strengthen Slipstream’s position in the rapidly expanding market for outsourced IT services in life sciences. The company plans to use the capital to scale operations, enhance internal systems, and pursue expansion through both organic growth and strategic acquisitions.
Founded by CEO Brandon McKay, Slipstream delivers tailored IT and compliance-driven services designed to meet the complex regulatory needs of the pharmaceutical industry. Its offerings span Cloud CRM solutions, R&D and commercial services, IT support, artificial intelligence, and information management.
“The dynamic pharmaceutical regulatory environment requires a need for compliant capabilities with specific expertise around the industry,” said McKay. “We believe there are significant opportunities to further scale our platform. Our team is thrilled to partner with GreyLion and DGP.”
Slipstream’s core mission is to enable life sciences firms to streamline operations, adopt cutting-edge technologies, and improve patient outcomes by offering pragmatic and scalable IT solutions built around industry compliance.
GreyLion Partners, which focuses on growth-oriented middle-market investments, expressed confidence in Slipstream’s trajectory.
“We are excited for the opportunity to serve as a strategic partner to Brandon and the Slipstream management team,” said Henry Heinerscheid, Partner at GreyLion. His colleague, Ryan Anderson, added, “We believe there is a significant opportunity for Slipstream to continue to scale while maintaining its focus on providing best-in-class service.”
DGP, which first invested in Slipstream in 2022, praised the company’s progress and operational execution. “They’ve continued to expand the platform and solutions with strategic clarity and execution,” said Jesse Lane, DGP’s Founder and Managing Partner.
The investment was supported by a group of legal and financial advisors. Kirkland & Ellis advised the company, while Latham & Watkins represented GreyLion. DGP was advised by Choate Hall & Stewart, and management received counsel from Fox Rothschild. Guggenheim Securities served as Slipstream’s financial advisor.
With this latest backing, Slipstream is poised to deepen its footprint in the life sciences sector, addressing growing demand for specialized, compliant IT services that can keep pace with the industry’s rapid innovation and regulatory change.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.